Endoparaziter İlaçlar ve Toksisite

Yıl 2021, Cilt: 3 Sayı: 1, 30 - 34, 28.02.2021

Semih Korkut Nazlı Görmeli Kurt Hakan Oğuztürk Afşin Kayıpmaz

Öz

Paraziter hastalıklar, dünya çapında ciddi morbidite ve mortaliteye neden olarak insanlara ağır bedeller ödetmektedir. Bu derleme, insanlarda majör protozoan ve helmint enfeksiyonlarının tedavisi ve ilaç toksisitelerini gözden geçirmektedir. Umarız bu inceleme, bilim insanlarını ilaç toksisiteleri için gerekli ek bilgileri edinmeleri için teşvik edecektir.

Anahtar Kelimeler

Endoparazitler ilaçlar, Toksik etki, Yasal doz

Endoparasitary Drugs and Toxicity

Öz

Parasitic diseases cause substantial morbidity and mortality worldwide, taking the heaviest toll among the world’s people. This article reviews the treatment and drug toxicities of the major protozoan and helminth infections in humans. We hope this brief review will stimulate scientists to acquire additional information necessary for drug toxicities.

Anahtar Kelimeler

Endoparasiter drugs, Legal dose, Toxic effect

Kaynakça

• 1. Mandell GL, Bennet JE, Dolin R, ed. Principles and Practice of Infectious Diseases, 5 th ed. New York: Churchill Livingstone, 2000.
• 2. Unat EK, Yücel A, Altaş K, Samastı M, ed. İnsanın Ökaryonlu Parazitleri ve Bunlarla Oluşan Hastalıkları. Unatın Tıp Parazitolojisi. 5 inci baskı, İstanbul: Doyuran Matbaası, 1995.
• 3. Özcel MA, Altıntaş N, ed. Parazit Hastalıklarında Tanı. Türkiye Parazitoloji Derneği yayını, İzmir: Ege Üniversitesi Basımevi, 1997.
• 4. Ullmann's Encyclopedia of Industrial Chemistry. 6th ed.Vol 1: Federal Republic of Germany: Wiley-VCH Verlag GmbH & Co. 2003 to Present, p. V. 3 185
• 5. Currance, P.L. Clements, B. Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3Rd edition, Elsevier Mosby, St. Louis, MO 2005, p. 160
• 6. Briggs G.G, R.K. Freeman, S.J.Yaffe. A Reference Guide to Fetal and Neonatal Risk. DrugsinPregnancy and Lactation. 4Th ed. Baltimore, MD: Williams&Wilkins1994. p. 70
• 7. Vibhavari Sail, M. KyleHadden. Chapter Eighteen-Notch Pathway Modulators as Anticance Chemotherapeutics Annual Reports in Medicinal Chemistry Volume 47, 2012, p.267-280
• 8. "Agrochemicals Handbook," with updates, Hartley, D., and H. Kidd, eds., Nottingham, Royal Soc of Chemistry, 1983-86 Vol. A297, Pg. 1983,
• 9. Doenhoff MJ, Cioli D, Utzinger J: Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis. 2008;21(6):659
• 10. Sung-Tae Hong Albendazole and Praziquantel: Review and Safety Monitoring in Korea Infect Chemother. 2018 Mar; 50(1): 1–10.
• 11. Yurttaş L, Abu Mohsen U, Ozkan Y, Cobanoglu S, Levent S, Kaplancikli ZA Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives. J Enzyme Inhib Med Chem. 2016;31(6):1177-83.
• 12. Canton C, Ceballos L, Domínguez MP, Moreno L, Fiel C, Bernat G, Farías C, Lanusse C, Alvarez L Pharmaco-parasitological evaluation of the rico-bendazole plus levamisole nematodicidal combination in cattle.J Vet Phar-macol Ther. 2018 Feb;41(1):83-91.
• 13. Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS. Goldfrank's Toxicologic Emergencies, 8th ed., 2006
• 14. Gilbert DN, Moellering RC Jr, Sande MA. The Sanford guide to antimicro-bial therapy. 31 st edn. Hyde Park, VT: Antimicrobial Therapy, ine., 2001.
• 15. Moellering RC Jr: Principles and Practice of lnfectious Diseases. Mandell GL, Bennett JE, Dolin R (eds), 5th ed,Churchill Livingstone, Philadelphia, 2000